S2 Part 1: Processing and minor processing

Published Date: 16 Feb 2023

Dr. Jacob Sands and Dr. Jared Weiss talk about subtypes. ongoing clinical trials; sustained sustained response to treatment; And it is possible to use the word "cure" to treat a small breast cancer.

Read Full News

Latest News

S1 Episode 4: How Early Is Early Enough to Reverse MASLD?

Drs VanWagner and Chen discuss whether fatty liver is reversible, weight-loss targets, diet quality, exercise, and where GLP-1s and bariatric surgery fit into MASLD treatment.

ArteraAI: Current Indications in Prostate Cancer

From localized disease to recurrence, where can ArteraAI add actionable insight for patients with prostate cancer?

Teen With a Slowly Enlarging Annular Hyperkeratotic Papule

The lesion initially appeared as a small papule and gradually enlarged, with more noticeable growth in recent months. The lesion was not painful, pruritic, or bleeding.

Thyroid Surgery: Practical Strategies for Optimal Post-op Care

Drs Kaniksha Desai and Michael Yeh discuss practical aspects of postoperative thyroid surgery care.

What's Driving Pancreatic Cancer Risk?

From modifiable habits to genetic red flags, here's what raises pancreatic cancer risk, and when to screen for it.

Rapid Genetic Screening May Protect Newborn Hearing

A rapid bedside genetic test may help neonatologists avoid gentamicin-related hearing loss in newborns at the highest risk.

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Latest News

Drs VanWagner and Chen discuss whether fatty liver is reversible, weight-loss targets, diet quality, exercise, and where GLP-1s and bariatric surgery fit into MASLD treatment.

From localized disease to recurrence, where can ArteraAI add actionable insight for patients with prostate cancer?

The lesion initially appeared as a small papule and gradually enlarged, with more noticeable growth in recent months. The lesion was not painful, pruritic, or bleeding.

Drs Kaniksha Desai and Michael Yeh discuss practical aspects of postoperative thyroid surgery care.

From modifiable habits to genetic red flags, here's what raises pancreatic cancer risk, and when to screen for it.

A rapid bedside genetic test may help neonatologists avoid gentamicin-related hearing loss in newborns at the highest risk.

News All Time

Next Step for Australian UCCs: Ensuring Quality and Safety

Two recent surveys suggest eight ways in which quality care and safety can be promoted at Medicare urgent care clinics.

S3 Episode 6: Epidemiology of Endometrial Cancer

Drs Ursula A. Matulonis and Immaculata De Vivo discuss the epidemiology of endometrial cancer and how clinicians can use information about risk factors.

Game Changers: Navigating Zongertinib’s Role in HER2+ NSCLC

Dr Mark Kris discusses zongertinib in HER2+ NSCLC, detailing its efficacy, dosing, and key tolerability advantages.

Spotting Seborrheic Keratosis vs Melanoma in Primary Care

In primary care settings, recognizing the difference between seborrheic keratosis and melanoma can guide timely biopsy and reduce missed diagnoses.

Beyond Water and Oxalate: New Era in Kidney Stone Prevention

New approaches to kidney stone prevention are combining traditional diet therapy with insights from genetics, metabolomics, and the microbiome.

Lyme Disease 101: Stages, Testing, and Prevention

Not every Lyme case comes with a bullseye rash, and not every case needs a blood test. The Curbsiders clear up the confusion around Lyme's stages, testing, and coinfections.

Excess and Dysfunctional Fat as a Primary Driver of HFpEF

The role of excess and dysfunctional fat in the genesis of HFpEF is well recognized, likely representing a primary or major upstream contributing cause in the large majority of patients.

Primary or Substance-Induced Psychosis? How to Tell and Treat

Distinguishing substance-induced psychosis from primary psychotic disorders starts with the history. Dr Adjoa Smalls-Mantey reviews the diagnostic clues and treatment approach.

S1 Episode 6: Choosing Therapies for ATTR-CM in 2026

Drs Alexander and Urey walk through stabilizers vs silencers, pivotal trial data, and practical first line choices to help you select the right ATTR CM therapy for each patient.

Melanoma Clues Every PCP Should Know

A mole that stands out from the rest or keeps changing may be a warning sign. See how PCPs can use the ugly duckling sign and other clues in melanoma assessment.

Woman Develops Autoimmune/Inflammatory Syndrome After Filler

A woman develops autoimmune/inflammatory syndrome induced by adjuvants after hyaluronic acid filler and hyaluronidase exposure, with biopsy-confirmed acquired cutis laxa.

S1 Episode 3: Incidental Fatty Liver on Imaging: What Should You Do Next?

When fatty liver appears incidentally on imaging, "just lose weight" isn't enough. Dr Brandman explains how to use FIB-4, FibroScan, and ELF to triage who needs referral and who doesn't.

When to Worry About Pediatric Joint Pain

Which pediatric musculoskeletal complaints need an urgent workup? Dr Basco shares a systematic approach to identifying clinical red flags and serious pathology.

Fast Five Quiz: Presentation and Diagnosis of Psoriasis

How much do you know about the presentation and diagnosis of psoriasis? Test your knowledge with this quick quiz.

Skin Biopsy Essentials for Primary Care

Selecting the right biopsy technique is key to accurate diagnosis. Review practical guidance on shave and punch biopsies in primary care.

Pott’s Puffy Tumor in Teen Leads to Bilateral Blindness

A teen with Pott’s puffy tumor develops irreversible bilateral blindness after delayed diagnosis and intracranial complications, highlighting the importance of its early recognition.

Recommended News For You

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

An understudied type of breast cancer poses a lurking threat

The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.

Alternative breast imaging techniques beyond mammography.

Does Maintenance Therapy Extend Life in mCRC?

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

Recommended Articles For You

Tremelimumab: A Potential Breakthrough in Cancer Treatment 

How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies 

Essential Strategies in Hematology for Healthcare Excellence 

An Overview Of Daunorubicin: What Is It Used For And How Does It Work? 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

De-escalation Misses the Mark in Inflammatory Breast Cancer

2.

10-year study shows tomosynthesis improves breast cancer detection

3.

Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients

4.

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

5.

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

1.

Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning

2.

Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes

3.

The Significance of APTT Blood Test Results for Detecting Coagulation Disorders

4.

Precision Oncology Using Tumor Evolutionary Trajectory Modeling

5.

Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

2.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

3.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

4.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

5.

Diagnosis and Management in Hematology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot